Cancer Letters

METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance

Publication date: Available online 17 October 2022Source: Cancer LettersAuthor(s): Ye Zhang, Jian-Ge Qiu, Xiao-Yu Jia, Yu Ke, Ming-Kun Zhang, David Stieg, Wen-Jing Liu, Ling-Zhi Liu, Lin Wang, Bing-Hua Jiang

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

The treatment in patients with unresectable locally advanced non-small cell lung cancer: Explorations on hot issues

Publication date: Available online 17 October 2022Source: Cancer LettersAuthor(s): Yimeng Wang, Yao Wang, Jinming Yu, Xiangjiao Meng

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma

Publication date: Available online 17 October 2022Source: Cancer LettersAuthor(s): Yuxin Du, Yun Cai, Yan Lv, Lishen Zhang, Hao Yang, Quanzhong Liu, Ming Hong, Yue Teng, Weiyan Tang, Rong Ma, Jianqiu Wu, Jianzhong Wu, Qianghu Wang, Hongshan Chen, Kenin…

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression

Publication date: Available online 14 October 2022Source: Cancer LettersAuthor(s): Su-Yeon Lee, Sanghwa Kim, Yeonhwa Song, Namjeong Kim, Joohwan No, Kang Mo Kim, Haeng Ran Seo

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Editorial Board

Publication date: 1 December 2022Source: Cancer Letters, Volume 550Author(s):

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

CRISPRi screening identifies <em>CASP8AP2</em> as an essential viability factor in lung cancer controlling tumor cell death via the AP-1 pathway

Publication date: Available online 14 October 2022Source: Cancer LettersAuthor(s): Ksenia Myacheva, Andrew Walsh, Marisa Riester, Giulia Pelos, Jane Carl, Sven Diederichs

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Corrigendum to “Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells” [Cancer Lett. 369 (2015) 368–375]

Publication date: Available online 11 October 2022Source: Cancer LettersAuthor(s): Andreia F.A. Henriques, Patrícia Barros, Mary Pat Moyer, Paulo Matos, Peter Jordan

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Editorial Board

Publication date: 28 November 2022Source: Cancer Letters, Volume 549Author(s):

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Retraction notice to “Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3” [Canc. Lett. 478 (2020) 22–33]

Publication date: Available online 8 October 2022Source: Cancer LettersAuthor(s): Wei Zhang, Yahui Liu, Yu Fu, Wei Han, Hongji Xu, Lijia Wen, Yu Deng, Kai Li

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Retraction notice to “PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages” [Cancer Lett. 529 (2022) 19–36]

Publication date: Available online 8 October 2022Source: Cancer LettersAuthor(s): Ying Xu, Jiawei Lu, Yinbing Tang, Wenjie Xie, Heteng Zhang, Beibei Wang, Shouliang Zhang, Wenji Hou, Chen Zou, Pengcheng Jiang, Wenbo Zhang

By ScienceDirect Publication: Cancer Letters, 2 years ago